SPONSORED CONTENT
The 340B drug pricing program, which allows eligible healthcare providers known as covered entities to purchase medications at a reduced price, has been an incredibly valuable tool for providing affordable healthcare to underserved populations. However, the benefits of the 340B program
…SPONSORED CONTENT
Many people have been losing sleep thinking about how they should move forward in the current 340B environment. Over the last 18 months, it has felt like an external force is around every corner, pushing or pulling covered entities into new areas of discomfort.
…
Q: Where did you complete your professional training?
I graduated with an Honours Bachelor’s of Science from York University in Toronto, Canada in 1997 and a Bachelor of Science
…
SPONSORED CONTENT
TIP: When it comes to duplicate discount prevention, don’t assume that all 340B drugs are billed to Medicaid using the same NPI. Routine
SPONSORED CONTENT
TIP: The key to unlocking the full potential of your program starts with complete understanding of your data.
SPONSORED CONTENT
TIP: If your entity engages a firm to independently audit your 340B Program, follow through on the auditor’s recommendations in a timely manner.
SPONSORED CONTENT
Many covered entities are not aware of the opportunity to capture referral prescriptions. This includes ones that were initially determined to be non-eligible by your TPA but after a closer look in your EMR are deemed to be eligible. Don’t miss out
… SPONSORED CONTENT
TIP: Don’t forget that in a replenishment model, 340B purchases are primarily made after determining eligibility through accumulated eligibility.
SPONSORED CONTENT
TIP: Make sure you are taking time to review your 340B wholesaler invoices at least weekly to ensure you are getting the correct
SPONSORED CONTENT
Resolving 340B noncompliance can be a time-consuming task for 340B participants — and one of the greatest challenges in managing a 340B program. This guide outlines the five steps to successfully navigate resolving compliance issues requiring repayment to manufacturers, from discovery to resolution, and includes
…
×
*Sign up for news summaries and alerts from 340B Report
